We have previously shown that DDA3 -also known as proline/serine-rich coiled-coil protein 1 (PSRC1) -is a microtubule-associated protein that promotes cell growth by stimulating the b-catenin pathway. Here, we report that DDA3 can bundle and stabilize microtubules in vivo and in vitro. We found that overexpression of DDA3 increased the abundance of acetylated and tyrosinated microtubules. We employed PC12 and N2a cell lines, as well as cultured hippocampal neurons, and demonstrated that overexpression of DDA3 suppressed neurite/axon outgrowth, whereas its depletion accelerated neurite/axon formation and elongation. Knockdown of DDA3 reduced b3tubulin levels in N2a cells, which contributed to the spontaneous neurite formation caused by DDA3 depletion. Consistent with its role in suppressing neuritogenesis, DDA3 was downregulated during induced neuronal differentiation. Moreover, expression of DDA3 was detected in the rat brain at embryonic (E) day E15 and in the cortical region at E17, the period of active neurogenesis. Levels of cortical DDA3 decreased at the beginning of E19, when active neuritogenesis is completed. Overall our results demonstrate that DDA3 is a so-farunknown microtubule-stabilizing protein that is involved in regulating neurite formation and elongation.
Introduction
Microtubules (MTs) are key structural components of the cytoskeleton that also participate in many cellular processes, including cell migration, division, morphogenesis and vesicle movement. MTs are composed of a and b tubulin dimers that are polymerized to form hollow tubular structures 25 nm in diameter; these structures can form organized arrays via crosslinking of parallel MT arrays. The a and b tubulin subunits in most organisms exist in multiple isoforms, which in their various combinations afford MTs their functional diversity. MTs are subject to multiple enzymatic modifications, and acetylation on Lys-40 of a-tubulin (L' Hernault and Rosenbaum, 1985) is frequently found on stable MTs, such as those present in the spindle and midbody. In addition, a-tubulin undergoes cycles of detyrosination and retyrosination at its C-terminus by tubulin carboxypeptidase (TCP) (Argaraña et al., 1978; Fonrose et al., 2007) and tubulin tyrosine ligase (TTL) (Arce et al., 1975) , respectively. In general, the long-lived, stabilized MTs are more susceptible to proteolytic removal of the tyrosine residue, resulting in detyrosinated MT or Glu-MT, which can be detected by specific antibodies. To date, the biological significance of these post-translational modifications (PTMs) remains unclear. Acetylation of tubulin has been demonstrated to affect cell migration, and overexpression of the MT deacetylase HDAC6 (Hubbert et al., 2002) within cells results in increased cell migration (Haggarty et al., 2003) . However, a recent study indicated that acetylation of a-tubulin by Elongator, a component of the histone acetyltransferase complex, leads to increased migration of cortical neurons (Creppe et al., 2009) . It has been reported that an abundance of Glu-MTs correlates with tumor invasiveness and poor prognosis (Mialhe et al., 2001; Kato et al., 2004; Souček et al., 2006) . Additionally, mice deficient in TTL die prenatally due to disorganization of neuronal circuits, suggesting that tyrosinated MTs may be involved in neurite formation (Erck et al., 2005) .
MTs are highly dynamic structures that undergo continual phases of growth and shrinkage within cells (Mitchison and Kirschner, 1984) . This instability is based on the innate characteristics of a/b heterodimers (Burbank and Mitchison, 2006; Nogales and Wang, 2006) and is regulated by a complex hierarchy of diverse MT-associated proteins (MAPs). The ability to dynamically alter their assembly allows MTs to rapidly respond to external stimuli and fulfill a variety of cellular activities, including neuronal morphogenesis, the process by which neurons extend dendrites and axons.
In cultured hippocampal neurons, the development of neurite begins when several neurites sprout from cell bodies. Only one neurite grows to form the axon; the rest form dendrites. Both axons and dendrites contain a neurite shaft rich in tightly bundled MTs. At the tip of each neurite is the growth cone, which is important for neurite elongation and guidance in response to environmental cues. Growth cones contain actin and MT cytoskeletons. Filopodia and lamellipodia, the dynamic actin cytoskeletons, protrude from the leading edge of a growth cone. MTs are predominantly located in the central domain but can occasionally penetrate into the peripheral domain via a process of dynamic instability, thus entering the actin network of differentiating growth cones. Numerous MT-stabilizing proteins have been shown to be involved in neurite formation. For Journal of Cell Science example, overexpression and knockdown experiments have demonstrated that MAP2 plays an important role in promoting neurite elongation (Caceres and Kosik, 1990; Kanai et al., 1989; González-Billault et al., 2002) . Adenomatous polyposis coli (APC) is another MT stabilization protein that is enriched at the tip of the growth cone (Votin et al., 2005) and modulates the extension and steering of the axon (Koester et al., 2007) . However, it is interesting to note that the catecholaminergic cell clone CAD, which lacks expression of the major MT-stabilizing proteins such as MAP2 and MAP1B, can nevertheless maintain a normal neuronal architecture and elongate neurites at the same rate as hippocampal neurons (Bisig et al., 2009) . DDA3 was originally identified as a DNA damage-induced p53 transcriptional target through the mRNA differential display from a mouse cell line (Lo et al., 1999) . Mouse DDA3 encodes a protein of 329 amino acids rich in serine and proline, and contains a coiled-coil region plus six putative SH3-domain binding motifs PXXP. Although DDA3 does not contain a consensus MT-binding domain, it binds to MTs directy with its C-terminal region, and this binding was shown to enhance the rate of MT polymerization in an in vitro assay (Hsieh et al., 2007) . Little is known about the biological function of DDA3. It has been shown that human DDA3 is a regulator of mitotic spindle dynamics whose depletion leads to an increase of unaligned chromosome and a decrease in the velocity of chromosome segregation (Jang et al., 2008; Jang and Fang, 2009) . We have reported that deficiency of DDA3 suppressed cell growth by inhibiting the b-catenin-dependent signaling (Hsieh et al., 2007) . DDA3 interacts with EB3 and APC2, the neuron-specific homologue of APC that participates in many MT-mediated activities. EB3 has recently been shown to promote neurite formation via interactions with the F-actin-associated protein Drebrin at the growth cone (Geraldo et al., 2008) . Similar to EB3 and APC2, DDA3 is enriched in the brain (Lo and Wang, 2002) . In this study, we aimed to elucidate the effects of DDA3 on MT stability and explore its role in neurite formation. Here, we report that DDA3 bundles and exerts a distinctive PTM pattern on MTs. Using cultured hippocampal neurons, we have demonstrated that DDA3 inhibits neurite/axon formation and elongation, which is consistent with its expression pattern during the differentiation of cultured hippocampal neurons and the development of neurons in the rat brain. Together, our findings show that DDA3 is an MT-stabilizing protein and a novel regulator of neurite formation.
Results

DDA3 bundles and stabilizes MTs
We have previously shown that DDA3 binds to MTs with an in vitro MT binding assay, and here, we further examined its effect on MT stability. Transfection of the cells with plasmids expressing EGFP-DDA3 showed that DDA3 was mainly colocalized with tubulin in the cytoplasm and manifested as an MT-fibrous network (Fig. 1A, top ). With increasing levels of DDA3 expression, dense circular MT filaments aligning the area around the nucleus were observed (Fig. 1A, bottom ). When the cells transfected with DDA3 were exposed to the MTdepolymerizing agent nocodazole (4 mM), the MTs remained stable in the DDA3-overexpressing cells (Fig. 1B , arrow) but were completely disassembled in the adjacent cells without DDA3 overexpression (arrowhead). To address whether MT stabilization is a direct effect of DDA3 binding, an in vitro MT bundling assay was performed. The rhodamine-labeled MTs were incubated with purified GST or GST-DDA3, and their morphology was examined under a fluorescence microscope. As indicated in Fig. 1C , top, the addition of GST-DDA3 but not GST bundled the MTs. The bundle formation was clearly revealed by electron microscopy (Fig. 1C, bottom) , and the diameter of the MT formation increased from approximately 25 nm in the absence of DDA3 to 250 nm in its presence, indicating that bundling was a direct consequence of DDA3 binding. Furthermore, the DDA3-induced MT bundles were resistant to cold-induced depolymerization (Fig. 1D ). Domains of DDA3 responsible for bundling MTs were determined by an in vitro MT bundling assay. Plasmids expressing a series of GST-tagged DDA3 deletion mutants were constructed, and the purified GSTfusion proteins were reacted with rhodamine-labeled MTs. As shown in Fig. 1E and summarized in Fig. 1F , truncated mutants carrying the central (a.a. 118-241) or the C-terminal (a.a. 242-329) region of DDA3 displayed MT-bundling activity. Together, these findings indicate that DDA3 bundles and stabilizes MTs in vitro and in vivo.
DDA3 increases the abundance of acetylated and tyrosinated MTs
Given that stabilized MTs are more susceptible to PTMs such as acetylation and detyrosination, we examined whether DDA3associated MTs are distinctively modified. Immunofluorescence analysis using a Glu-MT-specific antibody to detect detyrosinated MTs ( Fig. 2A ) and summarized in Fig. 2B showed that overexpression of DDA3 (arrows), compared to vectortransfection control, significantly decreased the Glu-MT-positive cells. This suggests that DDA3 either inhibited detyrosination or promoted retyrosination of MTs. However, analysis of acetylated MTs with immunofluorescence indicated that nearly all DDA3expressing cells contained acetylated MTs (Fig. 2C, top) . The effect of DDA3 on the PTMs of MTs was specific because overexpression of EB3, a DDA3-interacting protein, did not affect the abundance of Glu-MT ( Fig. 2A , bottom, and 2B), and acetylation of MTs was a rare event in EB3-expressing cells (Fig. 2C , bottom).
Overexpression of DDA3 inhibits neurite/axon formation in cultured cells
We have previously shown that the DDA3 gene is expressed in the adult and fetal brain (Lo and Wang, 2002) , but its function remains largely unexplored. We examined its effect on neurite formation, which requires spatially and temporally regulated MT remodeling. The EGFP-tagged DDA3 or EB3 was separately expressed in PC12 cells before treatment with NGF for neuronal differentiation, and cells with neurites that measured the size of the cell body in length were scored after 36 h of induction. As indicated in supplementary material Fig. S1A and summarized in supplementary material Fig. S1B , expression of DDA3 dosedependently suppressed, whereas EB3 moderately promoted the NGF-induced neurite formation. Similar results were observed in N2a neuroblastoma cells stimulated with retinoic acid for differentiation. As shown in Fig. 3A , retinoic acid-induced neurite outgrowth (upper) could be suppressed by overexpression of DDA3 (middle) but not EB3 (lower). Interestingly, the simultaneous expression of EB3 neutralized the inhibitory effect of DDA3 on the retinoic acid-induced neurite formation (Fig. 3B , compare arrow and arrowhead;
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The effect of DDA3 on neurite formation was further examined using hippocampal neurons, a widely used cell model for neuronal differentiation prepared from embryonic day 18 (E18) rats. Cells were transfected with EGFP-or EGFP-DDA3-expressing plasmid one day after plating (day in vitro 1, DIV1), and neurite formation was detected two days later (DIV3) by staining the cells with an antibody against neuron-specific b3tubulin (Tubb3). Neurites were grouped according to length; short denotes those between 1-2 cell bodies, and long indicates those longer than two cell bodies. Consistent with what has been C2C12 cells were transfected with EGFP-DDA3 by using lipofectamine, and immunofluorescence was performed after 24 h. Cells were incubated with a specific antibody against a-tubulin (1:2500 dilution), followed by incubation with rhodamine-conjugated goat anti-mouse IgG, and nuclei were detected by DAPI staining. As shown by fluorescence microscopy, DDA3 was predominantly localized to the MTs as a fibrous network (top row of images); with increasing levels of DDA3 expression, MTs bundled and surrounded the nucleus (arrows in bottom row of images). (B) DDA3-induced MT bundles are nocodazole resistant. C2C12 cells that express EGFP-DDA3 were treated with 4 mM of the MT-depolymerizing drug nocodazole for 1 h before they were fixed and incubated with an antibody against a-tubulin. As indicated, the formed MT bundles were resistant to nocodazole-induced depolymerization (arrows), whereas MT filaments were completely disrupted in the neighboring non-transfected cells (arrowheads). (C) In vitro, DDA3 bundles MTs directly. The MT-bundling activity of DDA3 was assessed by incubating purified GST-DDA3 protein (3 mM) with rhodamine-labeled MTs (3 mM) at 35˚C for 30 min and examining it under a fluorescence microscope (top) or an electron microscope (bottom). GST protein was shown as a negative control. Electron microscopy under high magnification (1,500,000 6) showed that DDA3 induced MT-bundle formation (lower right). Scale bar, 50 nm. (D) DDA3-induced MT bundles are resistant to cold-induced depolymerization in vitro. The rhodamine-labeled MTs were incubated with purified GST-DDA3 or GST for 30 min at 35˚C. The reaction mixtures were placed on ice for 1 h and viewed under a fluorescence microscope. As shown, MT bundles were resistant to cold treatment in the presence of DDA3 (lower right). (E) Mapping the MT-bundling domains of DDA3 by the in vitro bundling assay. Purified GST-fusion proteins containing the indicated regions of DDA3 (3 mM) or EB3 (3 mM) were mixed with rhodamine-labeled MTs (3 mM) at 35˚C for 30 min, and the mixture was then applied onto slides and examined under a fluorescence microscope (magnification 400 6). (F) A summary of the mapping results shown in E. The MT-bundling domains were mapped to amino acids (a.a.) 118-241 and 242-329 for DDA3. NLS, nuclear localization signal.
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observed in cultured cell lines, overexpression of DDA3 suppressed neuritogenesis: the population of cells bearing no neurites increased from 8% to 47% ( Fig. 3D ,E, P,0.001 compared with EGFP-vector control), and this increase was accompanied by a parallel decrease in cells containing long neurites from 64% to 18% (P,0.001). The question of whether the suppression of neurite outgrowth by DDA3 may be related to its MT-bundling ability was addressed by analyzing the dosedependent effects of taxol on neurite formation. Taxol has been shown to enhance MT stability, and at high concentrations, it can induce MT bundle formation (Jordan et al., 1993) . As shown in Fig. 3F , taxol exerted a biphasic effect on neurite outgrowth in hippocampal neurons: it promoted neurite formation at a low dose (3 nM) that stabilized yet did not bundle MTs (Jordan et al., 1993) , but it completely blocked neurite formation at higher doses when MT bundles became prominent (100 nM and 2 mM).
We examined whether DDA3 overexpression could inhibit axon formation by staining cells with antibodies against axonspecific marker Tau-1. As shown, approximately 83% of the EGFP-transfected control cells differentiated into neurons containing a single axon, whereas only 17% of the cells did not form an axon (Fig. 3G,H) . Overexpression of DDA3 reduced the axon-bearing cells to 27%, accompanied by a significant increase in the proportion of cells lacking an axon to 73% (Fig. 3G,H) . These results showed that DDA3 overexpression inhibited neurite outgrowth and suppressed the neuronal polarity progression that results in axon formation.
We next considered whether DDA3 might also be involved in neurite elongation in addition to suppressing the initiation of neurite formation. Thus, hippocampal neurons were plated on culture dishes on DIV0 and transfected with EGFP-or EGFP-DDA3-expressing plasmid on DIV3. Neurite lengths were assessed using Image J software on DIV3 and DIV5, and the distribution of actual neurite lengths is shown in supplementary material Fig. S2 . As indicated, in the absence of DDA3, neurite lengths followed a normal distribution. Overexpression of EGFP-DDA3 increased the frequency of cells containing short neurites. When presented as a boxplot graph, the data (Fig. 3I ) revealed that DDA3 decreased the median neurite length from 210 mm to 125 mm, suggesting that DDA3 suppressed the elongation of neurites in hippocampal neurons.
To exclude the possibility that suppression of neurite outgrowth by DDA3 was secondary to induced cytotoxicity, the DDA3-overexpressing hippocampal neurons were analyzed for apoptosis and necrosis by Propidium iodide (PI) staining (supplementary material Fig. S3A ) and TUNEL assay (supplementary material Fig. S3B ), respectively. Our results demonstrated that DDA3 did not exert a cytotoxic effect on hippocampal neurons.
Depletion of DDA3 promotes neurite/axon formation
Effects of endogenous DDA3 and EB3 on neurite outgrowth were examined using the previously established DDA3 (pS-DDA3) or EB3 (pS-EB3) depleted N2a clones (Hsieh et al., 2007) , and the pSuper vector-transfected clone (pS) was used as a control. As shown in Fig. 4A , retinoic acid induced neurite formation in the vector control pS cells, whereas depletion of DDA3 (pS-DDA3) resulted in spontaneous process formation in cells without retinoic acid treatment (Fig. 4A,B) . These processes, analogous to the retinoic acid-induced neurites, contained MT-rich shafts and were tipped with actin-rich growth cones (data not shown). In contrast, the EB3-depleted cells (pS-EB3) were resistant to retinoic acid treatment (Fig. 4A, bottom; Fig. 4B ). To verify that DDA3 depletion was indeed responsible for the enhanced neurite Cells were immuno-stained for the neuronal specific marker Tubb3 at 48 h after transfection, and neurite length was examined under a fluorescence microscope. (E) Quantification of the results from (D). Neurites with lengths of 1-2 cell bodies were categorized as short neurites, whereas those longer than two cell bodies were counted as long neurites. Data shown represent the mean 6 SEM from three independent experiments. ***P,0.001. (F) Dosage effects of taxol on neurite outgrowth in hippocampal neurons. Hippocampal neurons were cultured in the differentiation medium containing the indicated concentrations of taxol for 24 h. Cells were fixed and incubated with an antibody against Tubb3 (1:500 dilution), and neurite formation was viewed under a fluorescence microscope. Nuclei were detected with DAPI staining. (G) DDA3 suppresses axon formation in hippocampal neurons. The hippocampal neurons were transfected with EGFP or EGFP-DDA3 on DIV1 and stained for axon-specific marker Tau-1 (1:500 dilution) on DIV3. Axon formation was examined under a fluorescence microscope. (H) Quantitative results from (G). Cells containing one or more Tau-1 positive neurites were labeled as axon positive (+), whereas those negative for Tau-1 staining were counted as axon negative (2). Data represent the mean 6 SEM from three independent experiments. ***P,0.001. (I) DDA3 expression inhibits neurite elongation. Hippocampal neurons were plated on culture dishes and induced for differentiation on DIV0. Cells were transfected with EGFP or EGFP-DDA3 expressing plasmid on DIV3 and stained for Tubb3 on DIV5. Neurite lengths were measured by Image J software and are shown in supplementary material Fig. S2 . Quantification of the data is presented using a box-whisker plot. The line across the box indicates the median value; the box contains the 25-75% interquartile range, and the whiskers represent the highest and the lowest values. A P value of less than 0.0001 was determined using the Wilcoxon rank sum test to compare the difference in neurite lengths between EGFP and EGFP-DDA3 groups. Lysates were prepared and analyzed for DDA3 expression by immunoblotting using antibody against DDA3 (1:1000 dilution). (D) Cells were fixed and incubated with an antibody against a-tubulin (1:3000 dilution), followed by incubation with rhodamine-conjugated anti-mouse IgG. As shown, expression of EGFP-mtDDA3 (arrow) inhibited the neurite formation caused by DDA3-depletion. (E) DDA3 knockdown promotes neurite outgrowth in hippocampal neurons. The hippocampal neurons were transfected with pSUPER-DDA3-GFP (pS-DDA3-gfp) to deplete DDA3 expression or with control vector (pS-gfp) on DIV1. Immunofluorescence was performed two days later using antibody against Tubb3 (1:500 dilution) and rhodamine-conjugated anti-mouse antibody. (F) Quantification of the results shown in E. Data shown represent the mean 6 SEM from three independent experiments. no, neurite length shorter than one cell body; short, between one and two cell bodies; long, greater than two cell bodies. ***P,0.001. (G) Depletion of DDA3 promotes axon formation. Hippocampal neurons were transfected with pSUPER-DDA3-GFP (pS-DDA3-gfp) or control vector (pS-gfp) on DIV1. Two days after transfection, cells were incubated with antibody against Tau-1 (1:500 dilution), followed by rhodamine-conjugated anti-mouse antibody. (H) Quantification of the results shown in G. Data shown represent the mean 6 SEM from three independent experiments. ***P,0.001. outgrowth, an RNAi-resistant DDA3 construct (EGFP-mtDDA3) was reintroduced into the pS-DDA3 cells (Fig. 4C ). As shown in Fig. 4D , restoration of DDA3 expression inhibited the DDA3 depletion-induced neurite formation.
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To examine whether endogenous DDA3 is required for neurite/ axon formation in hippocampal neurons, cells were transfected with a vector containing DDA3-specific siRNA fused to GFP (pS-DDA3-gfp) or a control vector (pS-gfp) and analyzed for neurite formation using an antibody against Tubb3 (Fig. 4E ). As summarized in (Fig. 4F) , the results indicated that a majority of neurons showed neurite outgrowth as early as DIV3, whereas approximately 18% of cells bore neurites shorter than one cell body and were counted as neurite-lacking cells. Depletion of DDA3 caused a reduction in the proportion of neurite-lacking neurons to 1% accompanied by an increase in cells bearing long neurites. Immunocytochemical staining with an antibody against the axonal Tau-1 protein indicated that depletion of DDA3 reduced the population of axon-lacking cells from 16% to 6.5% compared to vector control groups. Nonetheless, DDA3 depletion led to a significant increase in axon-bearing neurons from 84% to 94% (P,0.001) (Fig. 4G,H) . Together these results suggest that depletion of endogenous DDA3 promotes neurite/axon outgrowth during neuronal differentiation.
Inhibition of Tubb3 contributes to the spontaneous neurite formation caused by DDA3 depletion in N2a cells
We have incidentally observed via immunoblotting that depletion of DDA3 in N2a cells reduced the levels of the neuron-specific Tubb3 (Fig. 5A ). This effect was specific because depletion of DDA3 with an shRNA against a second site also resulted in Tubb3-knockdown cells were established by using two shRNAs (sh-Tubb3-1 and sh-Tubb3-2) that targeted separate regions of Tubb3 gene. Effective Tubb3 knockdown was verified by immunoblotting (left). Cell morphology was observed under a phase contrast microscope (right). (C) Restoration of Tubb3 expression suppressed the Tubb3 depletion-induced neurite formation. N2a control cells (left) and Tubb3knockdown cells (right) were transfected with EGFP or an RNAi-resistant Tubb3 (EGFP-mtTubb3) plasmid by lipofection for 24 h. Cells were fixed and incubated with an antibody against a-tubulin (1:3000 dilution), followed by incubation with rhodamineconjugated anti-mouse IgG. As shown, expression of EGFP-mtTubb3 inhibited the neurite formation caused by Tubb3-depletion. (D) Overexpression of Tubb3 inhibits neurite outgrowth in N2a cells induced for differentiation. N2a cells were overexpressed with EGFP or EGFP-Tubb3 and treated with 15 mM retinoic acid for 24 h. Immunofluorescence was performed by incubation with an antibody against atubulin (1:3000 dilution), followed by a rhodamineconjugated anti-mouse IgG. (E) Tubb3 overexpression suppresses the DDA3 depletioninduced neurite formation. Plasmids that express EGFP or EGFP-Tubb3 were transfected into pS-DDA3 and pS control cells, which were then induced for differentiation by culture in low-serum medium (Opti-MEM) for 24 h. Cell morphology was analyzed by immunofluorescence.
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reduced Tubb3 expression (supplementary material Fig. S4 ). To address the effect of endogenous Tubb3 on neurite formation, we established stable clones by suppressing Tubb3 expression in N2a cells with two specific shRNAs (sh-Tubb3-1 and sh-Tubb3-2). As shown in (Fig. 5B, left) , both shRNAs effectively lowered the endogenous Tubb3 expression. Depletion of Tubb3 induced the formation of bipolar processes similar to those observed in pS-DDA3 cells, as shown by phase contrast microscopy (Fig. 5B,  right) . Moreover, overexpression of an RNAi-resistant Tubb3 in the Tubb3 knockdown cells suppressed the nurite formation exerted by Tubb3 depletion (Fig. 5C ). Likewise, overexpression of EGFP-Tubb3 into the control (pS) or DDA3-knockdown (pS-DDA3) cells before differentiation induction demonstrated that the neurite outgrowth induced by retinoic acid treatment (Fig. 5D ) or DDA3-depletion ( Fig. 5E ) could be inhibited by Tubb3 overexpression. These results indicate that reduced Tubb3 expression contributes to the loss of DDA3-induced neurite formation.
Expression of DDA3 during differentiation and embryonic development
Expression of DDA3 and EB3 during neuronal differentiation was examined. Consistent with their respective roles in neurite formation, immunoblot analysis showed that levels of DDA3 protein decreased, whereas those of EB3 increased, with the time of retinoic acid treatment in N2a cells (Fig. 6A ) and in differentiating hippocampal cells (Fig. 6B ). Expression of DDA3 during embryonic development was also analyzed. Because neurites of hippocampal neurons arise in a subregion-specific manner during embryonic and early postnatal life, we investigated temporal profiles of DDA3 and EB3 expression in cortical regions in which neurogenesis and morphogenesis take place over a definite interval. Because neither the cortex nor hippocampus is well-developed at E15, lysates prepared from the whole brain were used. As shown in Fig. 6C , expression of DDA3, which was previously found to stimulate cell proliferation, was detected at E15 and E17. Nonetheless, significantly lower levels of DDA3 were found in cortical tissues prepared from E19, P1 and adult rats, in which active neurite formation takes place. Interestingly, expression of EB3, which promotes neurite formation, was inversely correlated with that of DDA3.
Discussion
We have previously shown that DDA3 is a MAP that stimulates cell proliferation via activation of the b-catenin pathway, but little is known about its physiological function. Using NGFtreated PC12 cells and retinoic acid-induced N2a cells as neuronal differentiation model systems, we have demonstrated that the expression of DDA3 suppresses, while its depletion promotes, neurite formation. These results were further confirmed using cultured rat hippocampal neurons. We show that depletion of DDA3 promotes neurite/axon formation, whereas overexpression of DDA3 not only inhibits neurite/axon outgrowth but also prevents the developing neurites from further elongation. Together, our results demonstrate that DDA3 is a novel negative regulator of neurite formation.
Results from the in vitro bundling assay indicate that DDA3 exerts a direct effect on MT bundling, increasing the diameter of MT formation from 25 nm to 250 nm. The DDA3-induced MT bundles are resistant to cold treatment in vitro and to nocodazole treatment in vivo, suggesting that DDA3 increases MT stability. Many MAPs that accelerate tubulin assembly have been shown to promote neurite formation, which has led to the suggestion that MT stabilization may be one important mechanism for neuritogenesis (Tint et al., 2005; Caceres and Kosik, 1990; Kanai et al., 1989) . However, although the neurite shaft is composed mainly of stable MTs, the growth cones of advancing neurites contain highly dynamic MTs. It has become increasingly clear that maintaining MT dynamics by properly balancing MT assembly and disassembly is necessary for neurite development (Bisig et al., 2009) . This notion is supported by the finding that treatment of cells with agents that either enhance or disrupt MT stability can lead to the suppression of neurite outgrowth and axon extension. We have found that taxol promoted neurite formation at a low dose that stabilized but did not bundle MTs, whereas it blocked neurite formation at concentrations that induced MT bundling (Fig. 3F) ; these results indicate that maintaining a balance between MT stabilization and dynamic instability is essential for proper neurite formation. Given that DDA3 induces the formation of highly stable MT bundles, it is not surprising that although axonogenesis and neuritogenesis take place at different stages during hippocampal neuron differentiation, DDA3 not only inhibits axonogenesis (Fig. 3G ) but also the formation of minor processes, as evidenced by the significant increase in the proportion of neurons bearing no neurites (Fig. 3E) . However, the functional association between DDA3-induced MT stabilization and suppression of neurite , respectively, for the indicated times. Lysates were prepared for immunoblot analysis using antibodies specific against DDA3 and EB3. Expression of atubulin is shown as a protein loading control. As shown, levels of DDA3 protein decreased, whereas those of EB3 increased, during differentiation of N2a cells and hippocampal neurons (d0 to d9 indicate DIV0 to DIV9 for hippocampal neurons). Numbers are the relative fold of protein expression, quantified relative to DIV0 by densitometer scanning. (C) Expression of DDA3 and EB3 during different stages of brain development. Cortices were prepared from rat embryos at days 17 to 19 (E17-E19), and in postnatal (P1) and adult rats, expression of DDA3 and EB3 was detected using specific antibodies. *E15, the whole brain from a rat embryo was used.
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formation remains to be clarified. It is conceivable that a variety of other factors, including remodelers of the actin cytoskeleton and the interacting MAPs, may be involved in regulating proper neurite formation.
Our data suggest that one mechanism underlying DDA3 depletion-induced neuritogenesis may be related to decreased expression of the neuron-specific tubulin subtype Tubb3. We have shown that depletion of DDA3 in N2a cells significantly decreased the abundance of Tubb3. Overexpression of Tubb3 inhibited the enhancement of neuritogenesis induced by retinoic acid treatment or DDA3-depletion, suggesting that reduced Tubb3 expression is involved in the spontaneous neurite formation caused by DDA3 depletion. Tubb3 is expressed at high levels in the brain, and elevated Tubb3 expression is noted in cultured P19 embryonic carcinoma cells induced for neuronal differentiation (Falconer et al., 1992) . The reason for the subtypespecific tubulin expression in neurons remains unclear, but it may depend on the ability of Tubb3 to increase MT dynamic instability (Banerjee et al., 1990; Hari et al., 2003) , which is required for cytoskeleton remodeling in developing neurons. In contrast to Tubb3, DDA3 bundles MTs and inhibits their dynamics. The reduced levels of Tubb3 observed in DDA3depleted cells may indicate a compensatory effect to maintain the balanced MT dynamics that are required for neurite outgrowth. This again illustrates the intricate relationship between modulation of MT dynamics and neurite formation.
Our finding that depletion of EB3 led to suppressed neuritogenesis is consistent with a recent report showing that EB3 positively regulates neurite extension via interactions with the F-actin-associated protein Drebrin at the growth cone (Geraldo et al., 2008) . Based on the domain mapping results that both the Nand C-terminal regions of EB3 are involved in the binding to Drebrin (Geraldo et al., 2008) and DDA3 (Hsieh et al., 2007) , it is reasonable to speculate that overexpression of DDA3 may deplete the EB3 pool or alter its cellular localization, thereby interfering with the proper interaction with Drebrin required for neurite outgrowth. It is of interest to note that during induced neuronal differentiation of N2a and hippocampal cells, an abundance of DDA3 decreases whereas that of EB3 increases, which is consistent with their respective functions in neuritogenesis. Indeed, a reverse correlation in the expression of DDA3 and EB3 was observed not only in cultured cells but also in the brains of rats at different developmental ages (Fig. 6C) .
We have shown that overexpression of DDA3 increases the extent of MT acetylation and tyrosination. The causal relationships between DDA3-induced PTMs and MT bundling are unclear because stabilized MTs are prone to acetylation and detyrosination. Accumulating evidence indicates that acetylation or detyrosination alone does not necessarily lead to altered MT stability; rather, these PTMs are likely to be involved in the regulation of interactions between MTs and their associated proteins. For example, the C-terminal tyrosine of a-tubulin has been shown to be essential for binding to the cytoskeletonassociated glycine-rich (CAP-Gly) protein (Weisbrich et al., 2007) , whereas detyrosinated and acetylated tubulins exhibit preferential binding to kinesin-1, one of the earliest known axonal markers (Konishi and Setou, 2009) . Many studies indicate that MTs from axons, dendrites and growth cones exhibit distinct PTM patterns and, furthermore, that the composition and distribution of PTMs may change as cells undergo morphogenesis and differentiation. It remains to be determined whether the DDA3-induced changes in the PTMs of MTs could affect the recruitment of MAPs, thereby inhibiting neuritogenesis.
Neurite formation and axonogenesis are complex processes involving intricate interactions between dynamic actin and MT filaments, and they are regulated spatially and temporally by numerous actin and MT remodeling proteins. In the present study, we have identified DDA3 as a novel molecule suppressing MT dynamics and neurite formation. The finding that DDA3 can hamper neurite formation via modulation of Tubb3 suggests that DDA3 may be involved in the pathogenesis of Tubb3 syndromes.
Materials and Methods
Cell culture and transfection C2C12 mouse myoblast cells were cultured in DMEM medium containing 10% fetal bovine serum (FBS). NIH3T3 mouse fibroblast cells were grown in DMEM supplemented with 10% calf serum. PC12 rat pheochromocytoma cells were cultured in DMEM with 5% FBS and 10% horse serum (HS). The N2a mouse neuroblastoma cells were cultured in MEM medium with 10% FBS, 2 mM Lglutamine, 0.1 mM non-essential amino acids and 1 mM sodium pyruvate. All media were supplemented with 100 units/ml of penicillin and 100 mg/ml of streptomycin. Hippocampal neurons were prepared from fetal Sprague-Dawley rats on the 17-18 th day of gestation. Dissociated hippocampal neurons were suspended in MEM supplemented with 5% HS, 5% FBS, 2 mM L-glutamine, 0.6% glucose, 0.05 mg/ml insulin, 0.05 mg/ml transferin and 0.05 mg/ml selenite. Cells were plated at a density of 400 cells/mm 2 onto a poly D-lysine (0.1 mg/ml)-coated cover slip (DIV0). After 5 hours of incubation, the culture medium was replaced with B27/Neurobasal supplemented with 0.5 mM glutamine and 12.5 mM glutamate. One half of the medium was changed to glutamate-free B27/ Neurobasal every 4 days. Transfection was performed using LipofectAMINE PLUS reagent (Invitrogen, Carlsbad, California, USA) according to the manufacturer's instructions. All animal experiments were performed according to approved guidelines.
Immunofluorescence analysis
Immunofluorescence analysis for C2C12, NIH3T3, PC12 and N2a cells was performed as described previously (Hsieh et al., 2007) . For primary hippocampal neurons, cells were cultured on glass cover slips, fixed with 4% paraformaldehyde and 4% sucrose in PBS for 25 min, and permeabilized with 0.05% Triton X-100 in PBS for 15 min. The cover slips were incubated in PBS containing 3% FBS for 45 min and reacted with primary antibodies for 1 h at 37˚C, followed by reaction with appropriate secondary antibodies for 1 h at 37˚C. The mouse monoclonal antibodies for a-tubulin (clone B-5-1-2) and anti-acetylated tubulin were obtained from Sigma (St. Louis, Missouri, USA), and that for b3-tubulin was acquired from Covance (Princeton, New Jersey, USA). Anti-Tau-1 monoclonal antibody and anti-Glu-tubulin rabbit polyclonal antibody were obtained from Chemicon (Billerica, Massachusetts, USA). The FITC-conjugated anti-goat antibody, rhodamineconjugated anti-mouse antibody and rhodamine-conjugated anti-rabbit antibody were acquired from Jackson ImmunoResearch (West Grove, Pennsylvania, USA).
In vitro MT bundling assay
The in vitro MT bundling assay was performed using the Fluorescent Microtubules Biochem Kit TM (BK007R, cytoskeleton, Denver, Colorado, USA) according to the manufacturer's instructions. In brief, rhodamine-labeled MTs were prepared from bovine brain tubulin (TL238, Cytoskeleton) containing 20% rhodamine-labeled tubulin (TL331M, Cytoskeleton). Polymerization of MTs was achieved by incubating tubulin with GPEM buffer (80 mM Pipes pH 6.8, 1 mM MgCl 2 , 1 mM EGTA and 1 mM GTP) at 35˚C for 30 min. The rhodamine-labeled MTs (3 mM) were diluted with general tubulin buffer containing 2 mM taxol and incubated with GST-tagged proteins at a final concentration of 3 mM at 35˚C for 30 min. Mixtures were then diluted 10-fold with general tubulin buffer and applied to coverslips for observation under a fluorescence microscope.
Construction of plasmids expressing shRNA and RNAi-resistant DDA3
The shRNA-based strategy was adopted to knock down DDA3 and EB3 expression. For construction of plasmids harboring a DDA3-or EB3-knockdown sequence, two complementary 64 bp forward and reverse nucleotides containing 19 bp sense and antisense sequences, corresponding to nucleotides 101-119 of DDA3 and nucleotides 664-682 of EB3 gene, were synthesized, annealed and inserted into the BglII and HindIII sites of the pSUPER and pSUPER-GFP plasmids. Two Tubb3 shRNAs, sh-Tubb3-1 and sh-Tubb3-2, that target nucleotides 256-276 and 357-377 of the Tubb3 gene, respectively, were obtained from the National RNAi Core Facility, Taiwan. EGFP-mtDDA3, the RNAi-resistant expression plasmid, was constructed by introducing silent Journal of Cell Science mutations into the siRNA target site of DDA3, rendering it unresponsive to RNAi. The protein encoded by this construct is identical to EGFP-DDA3.
Statistical analysis
Values are expressed as the mean 6 standard error of the mean (mean 6 SEM) from at least three independent experiments. Data were analyzed by Student's ttest for two-group comparisons, or by analysis of variance (ANOVA) followed by Turkey test for multiple comparisons among more than two groups. The nonparametric Wilcoxon rank sum test was used to compare neurite lengths between groups.
